30
Jan

Cancer drug developer Tracon Pharmaceuticals pulled in $36 million in an IPO, pricing well below its expected range as it works to get its top drug into late-stage trials.

…read more

Source: Tracon raises $36M in a downsized IPO

    

0 No comments